MedTrace Logo

Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children

NCT02624882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2018-08-02

No results posted yet for this study

Summary

Single-center prospective study to assess the clinical course of group A streptococcal blistering distal dactylitis in children after antibiotic treatment.

Conditions

  • Blistering Distal Dactylitis

Interventions

PROCEDURE

Positive rapid GAS test

If TDR positive, the child will be treated with antibiotics alone: * Amoxicillin 50mg / kg / day in 2 divided doses for 10 days (maximum dose 3 g / day in 2 divided doses) Or if allergic to penicillins and in the absence of cross-known allergy to cephalosporins * Cefpodoxime 8mg / kg / day in 2 divided doses for 10 days (maximum dose 400mg / day in 2 divided doses) J10 A control visit will review all the children included in the study. If the surgeon deems it necessary, the patient will be reviewed in consultation up to three months.

PROCEDURE

Negative rapid GAS test

Usual care

Sponsors & Collaborators

  • Camille JUNG

    lead OTHER

Principal Investigators

  • Camille Jung, MD, PhD · CHIC Créteil

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-01-31
Completion
2018-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02624882 on ClinicalTrials.gov